Holmes D, Suto E, Lee W, Ou Q, Gong Q, Smith H
J Exp Med. 2015; 212(7):1081-93.
PMID: 26077719
PMC: 4493413.
DOI: 10.1084/jem.20142130.
Li C, Mu R, Lu X, He J, Jia R, Li Z
J Immunol Res. 2014; 2014:672126.
PMID: 24860837
PMC: 4016860.
DOI: 10.1155/2014/672126.
Jasin H, Orozco J, ZIFF M
J Clin Invest. 1974; 53(2):343-53.
PMID: 11344546
PMC: 301475.
DOI: 10.1172/JCI107566.
Winfield J, Fernsten P, Czyzyk J, Wang E, Marchalonis J
Springer Semin Immunopathol. 1994; 16(2-3):201-10.
PMID: 7716705
DOI: 10.1007/BF00197517.
MITTAL K
Indian J Pediatr. 1980; 47(388):349-59.
PMID: 7228235
DOI: 10.1007/BF02759824.
Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus.
Mahowald M, Dalmasso A
Ann Rheum Dis. 1982; 41(6):593-8.
PMID: 7149796
PMC: 1000990.
DOI: 10.1136/ard.41.6.593.
Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis.
Hibi T, Aiso S, Yoshida T, Watanabe M, Asakura H, Tsuru S
Clin Exp Immunol. 1982; 49(1):75-80.
PMID: 7127904
PMC: 1536665.
Failure to detect brain reactivity of lymphocytotoxins in cerebral lupus.
Pussell B, Blyth F, Charlesworth J
Clin Exp Immunol. 1982; 47(1):133-7.
PMID: 7094418
PMC: 1536348.
Thymocytotoxic antibodies in patients with autoimmune hemolytic anemia, systemic lupus erythematosus and lymphoproliferative diseases.
Fagiolo E
Blut. 1982; 44(4):225-30.
PMID: 6979365
DOI: 10.1007/BF00319908.
Studies of lymphocytotoxins in infectious mononucleosis: reduced lymphocyte killing in the acute phase.
Quin J, Charlesworth J, Lee C, Macdonald G
Clin Exp Immunol. 1980; 39(3):588-92.
PMID: 6966547
PMC: 1538144.
Lymphocytotoxins in rheumatoid arthritis: prevalence, lymphocyte specificity, and HLA-DR antigens.
Wooley P, Panayi G, Batchelor J
Ann Rheum Dis. 1981; 40(2):154-6.
PMID: 6939412
PMC: 1000697.
DOI: 10.1136/ard.40.2.154.
Antibody-mediated cellular cytotoxicity against Raji cells ADCC(Raji): evaluation of false positives in the detection of circulating immune complexes by Raji-cell assay.
Dasgupta M, Kovithavongs T, Schlaut J, Longenecker B, Dossetor J
J Clin Immunol. 1982; 2(3):197-204.
PMID: 6749886
DOI: 10.1007/BF00915222.
Factors affecting E-rosette forming ability in peripheral lymphocytes of insulin dependent diabetics.
Cattaneo R, Saibene V, Pescatori D, Mersi A, Pozza G
Diabetologia. 1980; 18(2):115-9.
PMID: 6245007
DOI: 10.1007/BF00290486.
Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.
Williams Jr R, Hughes G, Snaith M, Parry H, Diao E, Greaves M
J Clin Invest. 1980; 65(2):379-89.
PMID: 6153183
PMC: 371376.
DOI: 10.1172/JCI109681.
[Leukocyte isoantibodies. 3. Identification and characterization of monospecific HL-A antiserums for histocompatibility testing].
Bertrams J, Kuwert E, NOLL K
Z Med Mikrobiol Immunol. 1971; 156(2):132-48.
PMID: 5554810
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes.
Stastny P, ZIFF M
Clin Exp Immunol. 1971; 8(4):543-50.
PMID: 5103550
PMC: 1712965.
Studies of human sera with cytotoxic activity.
Williams Jr R, Emmons J, Yunis E
J Clin Invest. 1971; 50(7):1514-24.
PMID: 5090066
PMC: 292092.
DOI: 10.1172/JCI106637.
Antibody-associated lymphotoxin in acute infection.
Huang S, Lattos D, Nelson D, Reeb K, Hong R
J Clin Invest. 1973; 52(5):1033-40.
PMID: 4700482
PMC: 302357.
DOI: 10.1172/JCI107268.
Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
Messner R, Lindstrom F, Williams Jr R
J Clin Invest. 1973; 52(12):3046-56.
PMID: 4584345
PMC: 302579.
DOI: 10.1172/JCI107503.
Lymphocytotoxic antibodies in patients with systemic lupus erythematosus.
Ooi B, Orlina A, Pesce A, Mendoza N, MASAITIS L, POLLAK V
Clin Exp Immunol. 1974; 17(2):237-43.
PMID: 4466602
PMC: 1554021.
